HOMA2 Model (Computational):
Uses iterative computational model based on fasting C-peptide and glucose levels to estimate insulin resistance (HOMA2-IR)
From: | To: |
The HOMA2 (Homeostatic Model Assessment 2) with C-peptide is an updated computational model that estimates insulin resistance using fasting C-peptide and glucose levels. It provides a more accurate assessment than the original HOMA model, especially in various metabolic conditions.
The calculator uses the HOMA2 computational model which employs iterative mathematical algorithms to solve simultaneous equations representing:
Input Parameters: Fasting C-peptide and fasting glucose levels are used to compute HOMA2-IR, which quantifies insulin resistance.
Clinical Significance: HOMA2-IR provides valuable information about insulin resistance, which is crucial for diagnosing metabolic syndrome, type 2 diabetes risk assessment, and monitoring treatment effectiveness in various metabolic disorders.
Instructions: Enter fasting C-peptide level (in nmol/L or pmol/L) and fasting glucose level (in mg/dL or mmol/L). Ensure measurements are taken after an overnight fast for accurate results.
Q1: Why use C-peptide instead of insulin?
A: C-peptide has a longer half-life, provides more stable measurements, and better reflects endogenous insulin secretion, especially in insulin-treated patients.
Q2: What are normal HOMA2-IR values?
A: Typically, HOMA2-IR values below 1.0 indicate normal insulin sensitivity, while values above 1.8-2.0 suggest insulin resistance.
Q3: When should this test be performed?
A: Morning fasting sample after 8-12 hours of overnight fasting is recommended for accurate results.
Q4: Are there limitations to HOMA2 model?
A: The model assumes steady-state conditions and may be less accurate in extreme metabolic states, liver disease, or renal impairment.
Q5: How does HOMA2 differ from original HOMA?
A: HOMA2 uses a computational model rather than a simple formula, accounts for renal glucose excretion, and provides separate estimates for insulin resistance and beta-cell function.